Epidemiological Features of New Coronavirus Infection (COVID-19). Communication 1: Modes of Implementation of Preventive and Anti-Epidemic Measures-Reference-Cited by-同舟云学术

Epidemiological Features of New Coronavirus Infection (COVID-19). Communication 1: Modes of Implementation of Preventive and Anti-Epidemic Measures

Published:2020-04-23 Issue:1 Volume: Page:6-13
ISSN:2658-719X
Container-title:Problems of Particularly Dangerous Infections
language:
Short-container-title:Problemy Osobo Opasnykh Infektsii

Author:

Kutyrev V. V.¹,Popova A. Yu.²,Smolensky V. Yu.³,Ezhlova E. B.³,Demina Yu. V.²,Safronov V. A.¹,Karnaukhov I. G.¹,Ivanova A V.¹,Shcherbakova S. A.¹

Affiliation:

1. Russian Research Anti-Plague Institute “Microbe”

2. Federal Service for Surveillance in the Sphere of Consumers Rights Protection and Human Welfare; Russian Medical Academy of Continuing Professional Education

3. Federal Service for Surveillance in the Sphere of Consumers Rights Protection and Human Welfare

Abstract

The review analyses the information on the epidemiological situation on COVID-19 around the world. Presented is the assessment of the major epidemiological parameters (basic reproductive rate, lethality, incubation period, and serial interval). Demonstrated is the share of severe cases among different age groups and the general structure of incidence by the severity of clinical course. The paper provides the classification of response models internationally depending upon the complex of measures undertaken at different stages of epidemic process. Reviewed are the key response actions to control the COVID-19 transmission in different countries of the world and the Russian Federation and given is the assessment of their effectiveness.

Publisher

Russian Research Anti-Plague Institute Microbe

Subject

Infectious Diseases,Microbiology (medical),Immunology,Microbiology,Epidemiology

Reference20 articles.

1. WHO Director-General’s opening remarks at the media briefing on COVID-19 – 3 March 2020. World Health Organization, March 3, 2020 (cited 1 Apr 2020). [Internet]. Available from: https://www.who.int/dg/speeches/detail/who-director-general-s-openingremarks-at-the-media-briefing-on-covid-19---3-march-2020.

2. Virtual press conference on COVID-19. 11 March 2020 (cited 1 Apr 2020). [Internet]. Available from: https://www.who.int/docs/default-source/coronaviruse/transcripts/who-audio-emer-gencies-coronavirus-press-conference-full-and-final-11mar2020.pdf?sfvrsn=cb432bb3_2.

3. Novel Coronavirus – China. Disease outbreak news: Update 12 January 2020 (cited 1 Apr 2020). [Internet]. Available from: https://www.who.int/csr/don/12-january-2020-novel-coronaviruschina/en/.

4. Chaolin Huang, Yeming Wang, Xingwang Li, Lili Ren, Jianping Zhao, Yi Hu, Li Zhang, Guohui Fan, Jiuyang Xu, XiaoyingGu, Zhenshun Cheng, Ting Yu, Jiaan Xia, Yuan Wei, Wenjuan Wu, XueleiXie, Wen Yin, Hui Li, Min Liu, Yan Xiao, Hong Gao, Li Guo, JungangXie, Guangfa Wang, Rongmeng Jiang, Zhancheng Gao, Qi Jin, Jianwei Wang, Bin Cao. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020; 395(10223):497–506. DOI: 10.1016/S0140-6736(20)30183-5.

5. Nanshan Chen, Min Zhou, Xuan Dong, Jieming Qu, Fengyun Gong, Yang Han, Yang Qiu, Jingli Wang, Ying Liu, Yuan Wei, Jia’an Xia, Ting Yu, Xinxin Zhang, Li Zhang. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020; 395(10223):507–13. DOI: 10.1016/S0140-6736(20)30211-7.

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 Pandemic: Duration and Epidemiological Forecast;Problems of Particularly Dangerous Infections;2024-01-10

2. Comparative assessment of COVID-19 incidence among healthcare workers and general population in the city of Perm;Perm Medical Journal;2023-12-18

3. Epidemic manifestations of coronavirus infection caused by «omicron» genovariant in the Volgograd region;Journal of Volgograd State Medical University;2023-12-11

4. Similarities and Differences in the Manifestations of the COVID-19 Epidemic Process in Some Countries;Epidemiology and Vaccinal Prevention;2023-11-11

5. Variability of the SARS-CoV-2 Virus and the Susceptibility of the Population in the Dynamics of the Development of the Epidemic Process;Epidemiology and Vaccinal Prevention;2023-11-10